BioCentury
ARTICLE | Clinical News

Herceptin trastuzumab: Completed Phase III enrollment

August 1, 2011 7:00 AM UTC

Genentech Inc., South San Francisco, Calif. Chugai Pharmaceutical Co. Ltd. (Tokyo:4519), Tokyo, Japan GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. Roche (SIX:ROG; OTCQX:RHHBY), Basel, Swit...